1 – 33 of 33
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Putaminal T1/T2-weighted ratio is increased in PSP compared to PD and healthy controls, a multi-cohort study
(
- Contribution to journal › Article
-
Mark
Progressive QTc prolongation and reduced heart rate variability in dementia with Lewy bodies compared to Alzheimer's disease
(
- Contribution to journal › Article
- 2023
-
Mark
Performance of [18F]RO948 PET, MRI and CSF neurofilament light in the differential diagnosis of progressive supranuclear palsy
(
- Contribution to journal › Article
-
Mark
Whole exome sequencing of familial, combined or complex dystonia
(
- Contribution to journal › Published meeting abstract
-
Mark
A Swedish SCA34 family with late onset ataxia, cerebellar atrophy and ocular movement abnormalities with a novel mutation in ELOVL4
(
- Contribution to journal › Published meeting abstract
-
Mark
Patient perspective in hereditary ataxia
(
- Contribution to journal › Published meeting abstract
-
Mark
Genomic analyses of a large Swedish multi-incident kindred with autosomal dominant Parkinson’s disease with dementia
(
- Contribution to journal › Published meeting abstract
-
Mark
Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum : Revelations from the MANAGE-PD validation cohort
(
- Contribution to journal › Article
- 2022
-
Mark
A relatively common hypomorphic variant in WARS2 causes monogenic disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Unraveling Parkinson's disease heterogeneity using subtypes based on multimodal data
(
- Contribution to journal › Article
-
Mark
Decreased CSF oxytocin relates to measures of social cognitive impairment in Huntington's disease patients
(
- Contribution to journal › Article
- 2021
-
Mark
The neurological and neuropsychiatric spectrum of adults with late-treated phenylketonuria
(
- Contribution to journal › Article
-
Mark
Dopaminergic and serotonergic alterations in plasma in three groups of dystonia patients
(
- Contribution to journal › Article
-
Mark
Digital health technology for non-motor symptoms in people with Parkinson's disease : Futile or future?
(
- Contribution to journal › Scientific review
-
Mark
Validation and clinical value of the MANAGE-PD tool : A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
(
- Contribution to journal › Article
- 2020
-
Mark
Abstracts of the IAPRD XXV World Congress on Parkinson's Disease and Related Disorders, 2020. Congress theme : Diagnosing and treating movement disorders in the era of personalized medicine
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Do variants in IRF2BPL cause both neurological disorders and keratoconus 8?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
New generation genetic testing entering the clinic
(
- Contribution to journal › Article
-
Mark
The late stage of Parkinson's –results of a large multinational study on motor and non-motor complications
(
- Contribution to journal › Article
-
Mark
A detailed description of the phenotypic spectrum of North Sea Progressive Myoclonus Epilepsy in a large cohort of seventeen patients
(
- Contribution to journal › Article
-
Mark
Disappearance of familially aggregated paralysis agitans in subsequent generations: a 135-year follow up study
(
- Contribution to journal › Published meeting abstract
-
Mark
Long term outcome of Parkinson’s disease and validation of a new clinical classification system.
(
- Contribution to journal › Published meeting abstract
-
Mark
Ataxia project in Scania, Sweden: Study outline and current status
(
- Contribution to journal › Published meeting abstract
-
Mark
Co-occurrence of leukoencephalopathy with ataxia and SPG56 in one family
(
- Contribution to journal › Published meeting abstract
- 2019
-
Mark
General and abdominal adiposity and the risk of Parkinson's disease : A prospective cohort study
(
- Contribution to journal › Article
-
Mark
Nationwide prevalence of primary dystonia, progressive ataxia and hereditary spastic paraplegia
(
- Contribution to journal › Article
-
Mark
Low prevalence of known pathogenic mutations in dominant PD genes : A Swedish multicenter study
(
- Contribution to journal › Article
- 2017
-
Mark
Levodopa-carbidopa intestinal gel in advanced Parkinson's : Final results of the GLORIA registry
(
- Contribution to journal › Article
-
Mark
Non-motor symptoms and quality of life in dopa-responsive dystonia patients
(
- Contribution to journal › Article
- 2016
-
Mark
Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease : An open-label prospective observational study of effectiveness, tolerability and healthcare costs
(
- Contribution to journal › Article
- 2015
-
Mark
Non-motor symptoms in genetically defined dystonia : Homogenous groups require systematic assessment
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse
(
- Contribution to journal › Article
- 2008
-
Mark
Involvement of the serotonin system in L-dopa-induced dyskinesias
(
- Contribution to journal › Article